Compare stocks

LGVN vs MLEC

Longeveron Inc. Common Stock and Moolec Science SA Ordinary Shares

Compare the businesses

Longeveron Inc. Common Stock

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Open LGVN dashboard ↗

Moolec Science SA Ordinary Shares

Moolec Science SA, a science-based ingredient company, engages in developing ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology in Cayman Islands and internationally. It produces animal proteins in plants to heal the meat production system. The company is based in Grand Cayman, Cayman Islands.

Open MLEC dashboard ↗

Sign in to keep comparing stocks

You've viewed 3 distinct stock or comparison pages today. Sign in for 10 views per day.

3 of 3 daily views used. Your allowance resets at midnight Eastern time. Refreshes and chart changes do not use another view.

New to NexusTrade? Create a free account.

Choose another comparison ↗